Zhaogang Sun | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Best Researcher Award

Zhaogang Sun
Beijing Chest Hospital affiliated to Capital Medical University
Zhaogang Sun
Affiliation Beijing Chest Hospital affiliated to Capital Medical University
Country China
Scopus ID 14833570400
Documents 110
Citations 1,460
h-index 20
Subject Area Medical Microbiology
Event Medical Lab Scientist Awards

The Best Researcher Award recognizes scholarly contributions and sustained academic impact in the field of Medical Microbiology. Zhaogang Sun, affiliated with Beijing Chest Hospital affiliated to Capital Medical University, has contributed to research activities associated with infectious diseases, laboratory diagnostics, and microbiological investigations. The researcher’s publication record indexed in Scopus demonstrates measurable scholarly influence through peer-reviewed articles, citation performance, and interdisciplinary collaborations in medical laboratory sciences.[1]

Abstract

This academic recognition article summarizes the professional achievements and research contributions of Zhaogang Sun in the field of Medical Microbiology. The researcher’s work demonstrates active participation in laboratory-oriented biomedical investigations, infectious disease studies, and clinical microbiology applications. Indexed publications and citation indicators reflect consistent scholarly engagement with contemporary microbiological challenges and translational laboratory science.[1] The Best Researcher Award highlights measurable academic productivity, scientific communication, and interdisciplinary relevance within modern medical laboratory research.[2]

Keywords

Medical Microbiology, Clinical Laboratory Science, Tuberculosis Research, Infectious Disease Diagnostics, Microbial Pathogenesis, Laboratory Medicine

Introduction

Medical Microbiology remains an essential discipline within laboratory medicine, supporting disease diagnosis, pathogen identification, antimicrobial research, and epidemiological surveillance. Researchers operating within this field contribute to healthcare systems through evidence-based investigations and laboratory innovation.[3] Zhaogang Sun has participated in scientific research associated with microbiological analysis and infectious disease management, contributing to the advancement of laboratory-driven healthcare strategies and scientific understanding.[1]

Research Profile

Zhaogang Sun is affiliated with Beijing Chest Hospital affiliated to Capital Medical University in China. The researcher’s Scopus profile records 110 indexed documents with approximately 1,460 citations and an h-index of 20, indicating sustained academic engagement and scholarly visibility in Medical Microbiology.[1]

Research Contributions

The research contributions of Zhaogang Sun include participation in studies related to laboratory diagnostics, microbial investigations, and infectious disease evaluation. These contributions support broader scientific efforts focused on improving disease detection and clinical laboratory workflows.[5]

Publications

Selected publication themes associated with the researcher’s academic record include microbiological diagnostics, infectious disease monitoring, and laboratory-based clinical investigations.[1]

Research Impact

Research impact within Medical Microbiology is frequently evaluated through publication quality, citation performance, collaborative engagement, and contribution to diagnostic and clinical advancements.[5] The researcher’s publication portfolio reflects sustained participation in these scholarly activities.

Award Suitability

Zhaogang Sun demonstrates characteristics commonly associated with eligibility for the Best Researcher Award, including publication productivity, citation impact, and scientific relevance within Medical Microbiology. The researcher’s documented scholarly contributions align with the objectives of the Medical Lab Scientist Awards, which recognize academic excellence, laboratory innovation, and research-based healthcare advancement.[4]

Conclusion

The Best Researcher Award article highlights the academic profile and scientific contributions of Zhaogang Sun in the field of Medical Microbiology. Through publication activity, citation performance, and participation in laboratory-oriented research, the researcher has contributed to the advancement of microbiological and clinical laboratory sciences. The documented scholarly record reflects continued engagement with evidence-based scientific inquiry and international academic dissemination.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Zhaogang Sun, Author ID 14833570400. Scopus.https://www.scopus.com/authid/detail.uri?authorId=14833570400
    2. Zhaogang Sun. (2026). Fabrication and Antimycobacterial Evaluation of Molybdenum Disulfide-Coated Titanium Alloy Scaffolds. https://pubs.acs.org/doi/10.1021/acsomega.5c10190
    3. Zhaogang Sun. (2026). Recent Advances in Tetrahedral Framework Nucleic Acids for Multimodal Synergistic Cancer Therapy. https://onlinelibrary.wiley.com/doi/full/10.1002/agt2.70330
    4. Medical Lab Scientist Awards. (n.d.). Research recognition and academic excellence framework. https://medicallabscientist.com/
    5. Zhaogang Sun. (2026). Therapeutic Nanoplatform Integrating Photothermal Effect and Silver Nanoparticles for the Treatment of Intracellular Mycobacterium tuberculosis. https://pubs.acs.org/doi/10.1021/acsami.5c23795

 

Naima Nur | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Best Researcher Award

Naima Nur
Management Science Research Centre, Bangladesh
Naima Nur
Affiliation Management Science Research Centre
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Medical Lab Scientist Awards
ORCID 0000-0002-6695-5294

The Best Researcher Award recognizes the scholarly contributions and research activities of Naima Nur, affiliated with the Management Science Research Centre in Bangladesh. The recognition highlights research engagement within the field of microbiology and related interdisciplinary scientific investigations. The award is associated with the Medical Lab Scientist Awards platform, which acknowledges academic achievement, publication impact, and research dissemination within laboratory and biomedical sciences.[1] The research profile demonstrates measurable scholarly activity through indexed publications, citations, and international research visibility.[2]

Abstract

The Best Researcher Award profile of Naima Nur presents an overview of academic contributions associated with microbiology and laboratory-based scientific studies. The profile demonstrates participation in peer-reviewed publication activities and measurable scholarly metrics indexed through Scopus databases. Research visibility is reflected through citation accumulation, indexed documents, and collaborative scientific dissemination.[2] The award recognition aligns with international standards emphasizing publication quality, scientific relevance, and contribution to medical laboratory sciences.[3]

Keywords

Microbiology, Medical Laboratory Science, Research Recognition, Scientific Publications, Citation Analysis, Scopus Indexed Research

Introduction

Academic recognition awards are widely used to acknowledge scholarly productivity, scientific innovation, and contributions to specialized research domains. Within microbiology and medical laboratory sciences, awards frequently consider publication quality, research impact, and interdisciplinary relevance.[4] Naima Nur’s academic profile demonstrates engagement with internationally indexed research dissemination and scientific communication through peer-reviewed outputs and citation activity.[1]

Research Profile

Naima Nur is affiliated with the Management Science Research Centre in Bangladesh and has contributed to microbiology-oriented academic investigations. The research profile indexed under Scopus Author ID 57297459000 includes multiple scholarly publications with measurable citation activity.[1] Bibliometric indicators such as document count, citation frequency, and h-index are commonly used to evaluate academic visibility and research continuity within scientific communities.[1]

Research Contributions

The research contributions associated with Naima Nur include participation in scientific discussions related to microbiological methodologies, laboratory practices, and biomedical analytical frameworks. Research dissemination through indexed journals contributes to evidence-based scientific communication and enhances the accessibility of microbiological findings.[5]

Publications

The publication record associated with the researcher reflects participation in peer-reviewed academic dissemination. Indexed publications within microbiology and associated biomedical sciences support the visibility of scientific findings and contribute to citation-based evaluation metrics.[5]

Research Impact

Research impact is often evaluated through citations, scholarly engagement, and dissemination across international indexing systems. The citation profile associated with Naima Nur indicates that published works have contributed to ongoing academic referencing activities.[3] Citation-based indicators provide measurable evidence of research visibility and scientific interaction within the broader microbiology research community.[2]

Award Suitability

The Best Researcher Award recognition is aligned with measurable academic indicators including indexed publications, citation performance, and documented research engagement. The scholarly profile of Naima Nur demonstrates research participation relevant to microbiology and laboratory science disciplines.[1]

Conclusion

The Best Researcher Award profile of Naima Nur reflects academic participation in microbiology-related research and scholarly communication. Indexed publications, citation metrics, and affiliation with recognized research institutions collectively support the visibility of the research profile within international scientific databases.[2] The recognition associated with the Medical Lab Scientist Awards platform highlights contributions to laboratory science and the broader scientific research community.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57297459000
  2. Pathogens (20226). Patterns of Multidrug Resistance and Treatment Outcomes Among Pulmonary Tuberculosis Patients in Bangladesh. https://doi.org/10.3390/pathogens15020208
  3. International Journal of Infectious Diseases (2022). COVID-19 vaccine acceptance in South Asia: a multi-country study. https://doi.org/10.1016/j.ijid.2021.09.056
  4. Infectious Diseases of Poverty. (2021). Quality of life of COVID-19 recovered patients in Bangladesh. https://doi.org/10.1371/journal.pone.0257421
  5. Medical Lab Scientist Awards. (n.d.). Official Awards Platform.
    https://medicallabscientist.com/

Bineeta Kashyap | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Prof. Dr. Bineeta Kashyap | Microbiology | Research Excellence Award

Director Professor | University College Of Medical Sciences | India

Dr. Bineeta Kashyap is a research-focused medical microbiologist with sustained contributions to clinical microbiology, infectious diseases, and translational diagnostics. Her scholarly work spans tuberculosis, antimicrobial resistance, hospital-acquired infections, molecular diagnostics, mycology, immunological biomarkers, and infection control, with particular emphasis on clinically relevant and resource-adapted diagnostic strategies. She has authored 77 peer-reviewed research documents, reflecting methodological rigor and breadth across bacteriology, virology, mycology, and immunopathogenesis. Her research output has accrued 806 citations, underscoring consistent scientific impact and relevance to both laboratory and clinical practice, and she holds an h-index of 14, indicating a solid body of influential work. Her publications integrate molecular techniques, biomarker discovery, and epidemiological surveillance to address pressing challenges in infectious disease diagnosis and management. Collectively, her research demonstrates sustained academic productivity, interdisciplinary collaboration, and a strong commitment to evidence-based advancement of microbiological science.

Citation Metrics (Scopus)

1000

750

500

250

0

 

806
Citations

77
Documents

14
h-index

Citations

Documents

h-index

Featured Publications

Marino Venerito | Microbiology | Excellence in Translational Medicine Award

Published on by Medical Lab Scientist

Prof. Dr. Marino Venerito | Microbiology | Excellence in Translational Medicine Award

Senior Physician | Medical school in Magdeburg | Germany

Dr. Marino Venerito is a research-focused scholar whose work centers on gastrointestinal oncology, inflammatory diseases, and translational clinical outcomes. His publications emphasize evidence generation in hepatocellular carcinoma, gastric and colorectal malignancies, Helicobacter pylori–associated disorders, and real-world therapeutic effectiveness. Through multicenter studies, registry-based analyses, and retrospective cohorts, his research contributes to risk stratification, treatment optimization, and prognostic modeling in complex digestive diseases. He has authored 135 peer-reviewed documents spanning original research, collaborative analyses, and consensus-driven investigations, reflecting sustained engagement in high-impact clinical research. His scientific output has accumulated 3,653 citations, demonstrating broad international uptake and relevance across oncology and gastroenterology disciplines. With an h-index of 30, his body of work illustrates consistent citation performance and long-term influence, particularly in studies addressing treatment sequencing, outcome prediction, and population-level clinical data. Overall, his research portfolio highlights methodological rigor, collaborative scope, and measurable impact on contemporary gastrointestinal cancer research and informs future evidence-based clinical practice.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

3653
Citations

135
Documents

30
h-index

Citations

Documents

h-index

Featured Publications

Sourabh Kumar | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Sourabh Kumar | Microbiology | Research Excellence Award

Assistant Professor | Maharishi Markandeshwar Medical College and Hospital | India

Dr. Sourabh Kumar is an academic pathologist with a focused research portfolio spanning infectious diseases, hematopathology, and cardiovascular biomarkers. His scholarly work emphasizes Mycoplasma pneumoniae–associated pediatric respiratory infections and the clinicopathological relevance of platelet parameters and von Willebrand factor in valvular heart disease, particularly aortic stenosis. He has authored peer-reviewed articles in national and international medical journals and has contributed extensively to standard microbiology textbooks through multiple invited chapters covering infective syndromes, autoimmunity, hypersensitivity reactions, biomedical waste management, and microscopy. His research output demonstrates a translational approach, integrating laboratory diagnostics with clinical disease severity and prognostication. The body of work reflects sustained academic engagement, with 33 citations, 2 citable research documents, and an h-index of 1, indicating emerging impact in pathology and clinical microbiology literature.

Citation Metrics (Scopus)

40
30
20
10
0

33
Citations

2
Documents

1
h-index

Citations

Documents

h-index

Featured Publications

Debasish Biswal | Microbiology | Young Scientist Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Debasish Biswal | Microbiology | Young Scientist Award

Assistant Professor | All India Institute of Medical Sciences | India

Dr. Debasish Biswal is a medical microbiologist with a strong research portfolio focused on antimicrobial resistance, molecular diagnostics, infection prevention, and intensive-care–associated infections. His scholarly output comprises 26 peer-reviewed research documents, collectively accruing 45 citations with an h-index of 4, reflecting sustained impact across clinical and translational microbiology. His work spans carbapenemase detection, synergy testing of novel β-lactam/β-lactamase inhibitor combinations, rapid molecular diagnostics for bacterial meningitis and tuberculosis, and genomic epidemiology of multidrug-resistant pathogens. He has contributed to high-impact journals in medical microbiology, critical care, infectious diseases, and parasitology, often integrating laboratory diagnostics with clinical outcomes and infection control strategies. Ongoing research includes evaluation of next-generation antimicrobial combinations against extensively drug-resistant organisms and assessment of advanced molecular platforms for extrapulmonary tuberculosis. His research emphasizes evidence-based antimicrobial stewardship, surveillance of healthcare-associated infections, and translational diagnostics to inform policy and clinical practice.

Citation Metrics (Scopus)

50
40
30
20
10
0

45
Citations

26
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Hamid Rehman | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Hamid Rehman | Microbiology | Research Excellence Award

Doctor | Yıldız Technical University | Turkey

Dr. Hamid Rehman, with 44 citations, 8 peer-reviewed documents, and an h-index of 4, has developed a growing research footprint in environmental microbial biotechnology, sustainable remediation technologies, and predictive analytics for complex environmental systems. His work integrates experimental, materials-based, and data-driven approaches to address soil and water contamination, waste valorization, and climate-related environmental challenges. Dr. Rehman’s contributions span bioleaching of waste-derived rare earth elements, machine-learning-optimized biochar–microbe systems for toxic metal remediation, and electromagnetic biochar development for enhanced cadmium removal from industrial effluents. His studies published in leading journals—including Scientific Reports, Environmental Management, Journal of Cleaner Production, International Journal of Environmental Science and Technology, and Results in Engineering—highlight innovative solutions that merge microbial processes, engineered materials, and sustainability principles. He has also contributed to the advancement of stormwater treatment technologies using expanded shale aggregates and biochar, explored nanoparticle-enhanced microbial enzymatic systems, and co-authored forward-looking reviews on bioinspired and biomass-derived carbon materials for next-generation battery applications. Dr. Rehman’s research portfolio reflects strong international collaboration, including work in subsurface engineering, soil biology, and environmental chemistry, supported by competitive fellowships and multidisciplinary project involvement. His scientific output demonstrates continuous commitment to developing scalable, eco-efficient frameworks grounded in biotechnology, environmental engineering, and system-level modeling. In addition to his publications, Dr. Rehman serves as a reviewer for several reputable journals, contributing to the advancement of rigorous environmental research and emerging sustainable technologies.

Profiles: Scopus | ORCID  

Featured Publications

pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Published on by Medical Lab Scientist

Dr. pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Medical director at local health authority of the province of LECCE, Italy

Dr. Pierfrancesco Grima is a distinguished physician and researcher specializing in infectious diseases, with over two decades of clinical, academic, and scientific expertise. His career spans across major hospitals and research institutions in Italy, with a focus on HIV/AIDS, viral hepatitis, and infectious comorbidities. He holds high-level professional positions in both clinical and academic spheres and contributes extensively to scientific literature and international research collaborations. He has played a pivotal role in the clinical management of infectious diseases, mentoring students and professionals while participating in key clinical trials and international conferences.

profile

scopus

Education

Dr. Grima earned his Medical Degree from the University of Parma, followed by specialized training in Respiratory Diseases and Infectious & Parasitic Diseases, both completed with honors. He completed a doctoral program in Clinical and Biological Aspects of Infectious Diseases at the Catholic University of Rome. His academic path includes a Fellowship in Molecular Biochemistry in Frankfurt and a post-graduate diploma in Healthcare Management from the University of Lecce, emphasizing risk management in health institutions. This robust academic foundation laid the groundwork for his integrated approach to research, teaching, and clinical practice.

Experience

Since 2017, Dr. Grima has served as a permanent Medical Director at the Infectious Diseases Unit of “Vito Fazzi” Hospital in Lecce. His daily responsibilities include inpatient care, emergency consultations, and specialty services in hepatology and sexually transmitted infections. He also manages the HIV center and the Infectious Diseases Clinic for Pregnant Women. Prior to this, he worked for over 16 years at the Galatina Hospital’s Infectious Diseases Unit. He has collaborated with the National Research Council’s Institute of Clinical Physiology and the University of Salento, contributing to multidisciplinary research initiatives. Additionally, Dr. Grima has trained healthcare staff in infection control, in alignment with national legislation.

Research Interest

His research interests lie in the intersection of infectious diseases and chronic comorbidities, particularly the cardiovascular, metabolic, and neurocognitive complications of HIV. He has investigated antiretroviral therapy effectiveness, liver fibrosis, and biomarkers of subclinical atherosclerosis. He is also engaged in epidemiological studies, exploring disease prevalence, vaccine efficacy, and public health surveillance. Dr. Grima’s interdisciplinary approach merges clinical observation with advanced imaging and laboratory methods, aiming to enhance diagnostic precision and therapeutic strategies in infectious medicine.

Awards and Recognition

Dr. Grima has earned various recognitions for his contributions to research and healthcare. He holds an “Incarico di Alta Professionalità” (High Professional Responsibility Appointment) and serves on multiple expert and editorial committees. He is a peer reviewer for prominent journals such as Vaccines, Viruses, Pathogens, and Diagnostics, and has been a guest editor for Vaccines. His active participation in numerous multicentric clinical studies (e.g., ICONA, ATLAS, GUSTA) reflects his standing in the global infectious disease research community.

Publications

Dr. Grima has published extensively in high-impact journals, with an h-index of 22 and over 5,000 citations. Below are seven notable publications:

Grima P. et al. “Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.” J Infect, 2012; cited by 97 articles.

Grima P. et al. “Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome.” Scand J Infect Dis, 2012; cited by 58 articles.

Fabbiani M, Grima P. et al. “Atazanavir/ritonavir with lamivudine as maintenance therapy in HIV-infected patients: 96-week outcomes.” J Antimicrob Chemother, 2018; cited by 74 articles.

Grima P. et al. “Ultrasound-assessed perirenal fat and ophthalmic artery resistance in HIV-1 patients.” Cardiovasc Ultrasound, 2010; cited by 63 articles.

Guido M, Grima P. et al. “Human metapneumovirus and bocavirus in respiratory infections.” Virology, 2011; cited by 88 articles.

Grima P. et al. “Routine ultrasound-guided vs. echo-assisted biopsy in chronic hepatitis.” Radiol Med, 2008; cited by 35 articles.

Ciccarelli N, Grima P. et al. “Liver fibrosis and cognitive impairment in HIV patients.” Infection, 2019; cited by 66 articles.

Conclusion

Dr. Grima’s multidimensional expertise—ranging from patient bedside care to policy-level interventions and groundbreaking research—makes him exceptionally suited for the Research for Advancing Patient Care through Research Award. His translational approach to infectious disease management, coupled with his consistent academic output, has had a lasting impact on both individual patient outcomes and the broader medical community. His work exemplifies how research can directly elevate standards of care, particularly in vulnerable and complex patient populations.

Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.